<p>miR106a Promotes the Growth of Transplanted Breast Cancer and Decreases the Sensitivity of Transplanted Tumors to Cisplatin</p>

Faping You(Shengli Oilfield Central Hospital), Xuchen Cao(Tianjin Medical University Cancer Institute and Hospital)

Cancer Management and Research

January 1, 2020

10.2147/cmar.s231375

Cited by 13

Related Papers

Abstract PO1-27-01: Comparing the Efficacy and Safety of TQB2440 versus the Reference Pertuzumab for the Treatment of HER2-Positive Early or Locally Advanced Breast Cancer: A Multicenter, Randomized, Double-Blind, Parallel-Controlled Phase 3 Trial

|Cancer Research|2024|0